Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Ltd Live Price Chart
Performance
| Previous Close | ₹ 15.02 |
| High | ₹ 16 |
| Volume | 6590 |
| 52W Range | ₹ 12.71 - ₹ 31.49 |
| Open | ₹ 15.02 |
| Low | ₹ 15.02 |
| Market Cap | ₹ 21.57 Cr |
Venmax Drugs & Pharmaceuticals Ltd Technicals
| 20 Day | ₹ 14.773 |
| 50 Day | ₹ 15.643 |
| 100 Day | ₹ 17.499 |
| 200 Day | ₹ 19.835 |
| 20 Day | ₹ 14.734 |
| 50 Day | ₹ 15.507 |
| 100 Day | ₹ 17.515 |
| 200 Day | ₹ 21.505 |
Venmax Drugs & Pharmaceuticals Ltd Fundamentals
| ROCE | 2.034 |
| P/E Ratio | 79.050 |
| P/B Ratio | 1.050 |
| Industry P/E | 1.050 |
| Debt to Equity | 49.426 |
| ROE | 1.868 |
| EPS | 0.190 |
| Dividend Yield | 0.000 |
| Book Value | 14.368 |
| Face Value | 10.000 |
Venmax Drugs & Pharmaceuticals Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 8.1853 | 1.8605 | 0.1986 | 0.4193 | 1.983 |
| Total Expenses | 7.9083 | 1.8746 | 0.1117 | 0.1936 | 0.1364 |
| Profit After Tax | 0.2482 | -0.0105 | 0.0645 | 0.2256 | 1.8463 |
Venmax Drugs & Pharmaceuticals Ltd Shareholding Pattern
| Promoter Holdings | 10.464 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 74.340 % |
| Others - | 15.196 % |
About Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D. Planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand. ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 39.25 +0.56 (+1.45%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 507.65 -1 (-0.2%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 5,859.00 -28 (-0.48%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 673.00 +1.85 (+0.28%) |
| Abbott India Ltd Pharmaceuticals | ₹ 25,939.95 +250.6 (+0.98%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,318.65 -11.35 (-0.85%) |
FAQs on Venmax Drugs & Pharmaceuticals Ltd
1. Can I buy Venmax Drugs & Pharmaceuticals Ltd from PL Capital? ›
2. Does Venmax Drugs & Pharmaceuticals Ltd pay dividends? ›
3. What is the current share price of Venmax Drugs & Pharmaceuticals Ltd ? ›
4. What is the 52-week high and low of Venmax Drugs & Pharmaceuticals Ltd ? ›
5. What is the market capitalisation of Venmax Drugs & Pharmaceuticals Ltd? ›
6. What is the current P/E ratio of Venmax Drugs & Pharmaceuticals Ltd? ›
7. What is the current P/B ratio of Venmax Drugs & Pharmaceuticals Ltd? ›
8. What is the shareholding pattern of Venmax Drugs & Pharmaceuticals Ltd? ›
9. What is the 1-year return of Venmax Drugs & Pharmaceuticals Ltd? ›
Start SIP in Venmax Drugs & Pharmaceuticals Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
